skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Academic Search Premier remover Nome da Publicação: Bone Marrow Transplantation remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma

Huang, Jennifer ; Phillips, Sharon ; Byrne, Michael ; Chinratanalab, Wichai ; Engelhardt, Brian G ; Goodman, Stacey A ; Harrell, Shelton L ; Jagasia, Madan ; Kassim, Adetola ; Rawling, Kyle T ; Savani, Bipin N ; Sengsayadeth, Salyka ; Cornell, R Frank

Bone marrow transplantation (Basingstoke), 2018-06, Vol.53 (6), p.701-707 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era
EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era
Material Type:
Artigo 		Adicionar ao Meu Espaço

EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era

FOX, C. P ; BURNS, D ; LIM, Z ; COOK, G ; CARPENTER, B ; PETTITT, A. R ; MATHEW, S ; CONNELLY-SMITH, L ; YIN, J. A. L ; VISKADURAKI, M ; CHAKRAVERTY, R ; ORCHARD, K ; PARKER, A. N ; SHAW, B. E ; BYRNE, J. L ; BROOKES, C ; CRADDOCK, C. F ; CHAGANTI, S ; PEGGS, K. S ; HARVEY, C. M ; NATARAJAN, S ; MARKS, D. I ; JACKSON, B ; CHAKUPURAKAL, G ; DENNIS, M

Bone marrow transplantation (Basingstoke), 2014-02, Vol.49 (2), p.280-286 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients
High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients

Prediletto, Irene ; Farag, Sarah A ; Bacher, Ulrike ; Jeker, Barbara ; Mansouri Taleghani, Behrouz ; Brégy, Rachel ; Zander, Thilo ; Betticher, Daniel ; Egger, Thomas ; Novak, Urban ; Pabst, Thomas

Bone marrow transplantation (Basingstoke), 2019-12, Vol.54 (12), p.1923-1925 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants
Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants
Material Type:
Artigo 		Adicionar ao Meu Espaço

Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants

GOLDBERG, J. D ; ZHENG, J ; CASTRO-MALASPINA, H ; JAKUBOWSKI, A. A ; HELLER, G ; DEN BRINK, Mrm Van ; PERALES, M.-A

Bone marrow transplantation (Basingstoke), 2013-01, Vol.48 (1), p.99-104 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies
Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies

HAMAKI, T ; KAMI, M ; HEIKE, Y ; TANOSAKI, R ; MASUO, S ; MIYAKOSHI, S ; TANIGUCHI, S ; TOBINAI, K ; TAKAUE, Y ; KIM, S-W ; ONISHI, Y ; KISHI, Y ; MURASHIGE, N ; HORI, A ; KOJIMA, R ; SAKIYAMA, M ; IMATAKI, O

Bone marrow transplantation (Basingstoke), 2004-05, Vol.33 (9), p.891-900 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review
High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review
Material Type:
Artigo 		Adicionar ao Meu Espaço

High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review

Varga, Cindy ; Comenzo, Raymond L

Bone marrow transplantation (Basingstoke), 2019-04, Vol.54 (4), p.508-518 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Impact of frailty, melphalan pharmacokinetics, and pharmacogenetics on outcomes post autologous hematopoietic cell transplantation for multiple myeloma
Impact of frailty, melphalan pharmacokinetics, and pharmacogenetics on outcomes post autologous hematopoietic cell transplantation for multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of frailty, melphalan pharmacokinetics, and pharmacogenetics on outcomes post autologous hematopoietic cell transplantation for multiple myeloma

Nampoothiri, Ram V ; Kasudhan, Kripa Shanker ; Patil, Amol N ; Malhotra, Pankaj ; Khadwal, Alka ; Prakash, Gaurav ; Jain, Arihant ; Malhotra, Samir ; Verma Attri, Savita ; Varma, Neelam ; Varma, Subhash ; Lad, Deepesh P

Bone marrow transplantation (Basingstoke), 2019-12, Vol.54 (12), p.2088-2095 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide
Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide

Garnier, Alice ; Delbos, Florent ; Guillaume, Thierry ; Peterlin, Pierre ; Le Bourgeois, Amandine ; Béné, Marie C ; Le Bris, Yannick ; Malard, Stéphanie ; Duquesne, Alix ; Gauvrit, Isabelle ; Moreau, Philippe ; Cesbron, Anne ; Chevallier, Patrice

Bone marrow transplantation (Basingstoke), 2018-08, Vol.53 (8), p.1044-1047 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin's and non-Hodgkin's B-cell lymphoma
Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin's and non-Hodgkin's B-cell lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin's and non-Hodgkin's B-cell lymphoma

Joffe, E ; Rosenberg, D ; Rozovski, U ; Perry, C ; Kirgner, I ; Trestman, S ; Gur, O ; Aviv, F ; Sarid, N ; Kolomansky, A ; Gepstein, L ; Herishanu, Y ; Naparstek, E

Bone marrow transplantation (Basingstoke), 2018-01, Vol.53 (1), p.29-33 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation
Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation

Sidiqi, M Hasib ; Aljama, Mohammed A ; Muchtar, Eli ; Buadi, Francis K ; Warsame, Rahma ; Lacy, Martha Q ; Dispenzieri, Angela ; Dingli, David ; Leung, Nelson ; Gonsalves, Wilson I ; Kapoor, Prashant ; Kourelis, Taxiarchis V ; Hogan, William J ; Wolf, Robert C ; Kumar, Shaji K ; Gertz, Morie A

Bone marrow transplantation (Basingstoke), 2019-07, Vol.54 (7), p.1077-1081 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (403)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.